{"id":"0156dac6-d4d5-4d85-800a-9982d88b6b96","arxiv_id":"2607.12987","paper_version":2,"verdict":"CONDITIONAL","confidence":"MODERATE","novelty_score":6.0,"correctness_risk":"medium","formal_verification":"none","parameter_count":4,"one_line_summary":"A hybrid diffusion/inpainting pipeline grows a 656-image dermatology set into 266k synthetic images, lifting DDI malignancy classification to 90.9% and improving skin-tone fairness metrics.","lead":"This paper builds a generative pipeline that creates 266,000 synthetic skin-lesion images from 656 real ones, covering rare diseases and diverse skin tones. The synthetic data improves malignancy classification accuracy and fairness on the DDI benchmark, and the authors release the images, code, and models.","discovery_kind":"new_method","skeptic_critique":{"model":"deepseek-v4-flash","headline":"Potential test-set leakage through synthetics built from held-out healthy canvases threatens the synthetic-only/SOTA accuracy claim; the paper's one-line exclusion is insufficiently specified to rule it out.","rationale":"The reader's weakest assumption—label preservation in lesion mapping—is a valid premise about synthetic fidelity, but it is not the single most load-bearing concern. The reported 86.4%/90.9% accuracies could still be inflated even if every synthetic image perfectly preserves its disease label, provided the training set contains derived-from-test background information. The paper acknowledges leakage prevention in one sentence but gives no procedural detail, making the claim unfalsifiable from the manuscript alone. A concrete metadata-based audit of source-to-fold assignment would settle whether the benchmark is clean. This does not reject the paper; it reinforces the reader's CONDITIONAL verdict, as the released code/data should make such an audit straightforward. I therefore recommend UNCHANGED rather than a more severe adjustment, since the concern is about verification rather than demonstrated failure.","tokens_in":8578,"tokens_out":4609,"duration_ms":144396,"concrete_test":"Inspect the released synthetic dataset and code: for each of the five DDI folds, verify that every synthetic image used in training fold k has its source healthy canvas (and, for lesion-mapped samples, its donor lesion image) drawn exclusively from DDI images assigned to the other four folds. Re-run Exp. 1 and Exp. 2 after removing any synthetic whose source real image appears in that fold's test split; if accuracy or EOM shifts beyond one standard deviation, the SOTA claim is compromised.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The central claim—that cgDDI synthetics alone reach 86.4% and fine-tuned reach 90.9% SOTA—requires that the synthetic training set contain no information from the evaluation split. The paper states leakage prevention as 'excluding training synthetics conditioned on downstream test images' (Sec. 4.2), but the generation pipeline (Secs. 3.2–3.4) is described once, globally: 309 healthy synthetics are produced from 334 masked sDDI inputs, then lesion-mapped and semantic synthetics are built on those healthy canvases. If any healthy canvas was derived from a DDI image that appears in a fold's test set, then every lesion-mapped and semantic synthetic using that canvas inherits background features (ruler, skin texture, framing) of a test image. A ViT classifier can exploit such background identity cues, inflating both Exp. 1 and Exp. 2 accuracy and potentially the reported fairness gains. The paper does not describe per-fold generation, nor report how many synthetics were excluded under the leakage-prevention rule. This is more load-bearing than the reader's label-preservation concern: even if lesion-mapped images perfectly preserve the donor's disease label, test-set leakage alone would invalidate the benchmark comparison. The leaked-background mechanism is specific and testable from the released metadata.","agreement_with_reader":"partial"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper introduces cgDDI, a hybrid generative framework that expands a 656-image dermatology dataset (DDI) into 266k+ synthetic images through three mechanisms: inpainting-based healthy skin synthesis, non-parametric lesion mapping for rare diseases, and parametric semantic generation via textual inversion plus LoRA with prior-preservation loss. The authors evaluate malignancy classification and skin-tone fairness on DDI and Fitzpatrick17k, reporting 86.4% synthetic-only and 90.9% fine-tuned accuracy on DDI, with Equality of Opportunity improving from 69.6 to 86.6, and cross-dataset gains on F17k. All code, models, and synthetic images are released.","tokens_in":8851,"tokens_out":2826,"duration_ms":32521,"significance":"If the results hold, this is a valuable contribution to synthetic-data-augmented medical imaging: it is a rare openly released large synthetic dermatology corpus, it demonstrates single-sample disease augmentation, and it applies prior-preservation loss with healthy in-distribution anchors, a sensible and transferable idea. The authors also provide fairness metrics beyond accuracy and test on two datasets with different masking protocols. The central claims are plausible but currently rest on several unverified assumptions about leakage prevention and label preservation, and the statistical evidence for the headline deltas is thin.","major_comments":[{"comment":"The leakage-prevention statement is not sufficient to rule out test-set leakage. The healthy synthetics are generated once from 334 masked sDDI inputs (Sec. 3.2), and all lesion-mapped and semantic synthetics are built on those healthy canvases (Secs. 3.3–3.4). If any healthy canvas originated from a DDI image that appears in a fold's test set, every downstream synthetic inherits background cues (ruler, skin texture, framing) from that test image. The paper does not describe per-fold generation, does not report how many synthetics were excluded by the stated rule, and does not state whether the 309 healthy synthetics were derived from training-fold images only. This is load-bearing: a ViT can exploit such background identity cues, inflating both Exp. 1 and Exp. 2. Please specify the exact exclusion procedure, report excluded counts, or regenerate per fold.","section":"Sec. 4.2 / Sec. 3.2–3.4"},{"comment":"The DDI test set is only 131 images per fold and the F17k hold-out is 55 images. The headline improvements (e.g., 87.4% to 90.9%, EOM 69.6 to 86.6) correspond to a handful of images, and no confidence intervals or significance tests are reported. Please report bootstrap CIs or per-fold paired tests across the five seeds, especially for the fairness metrics whose standard deviations in Table 2 are large (DPM ±118, EOM ±1.9–4.3). Without this, the SOTA claim is not statistically grounded.","section":"Sec. 4.1 / Table 2"},{"comment":"The non-parametric lesion mapping assumes that a lesion transplanted onto a healthy canvas preserves the donor's disease identity and malignancy label even when moved to a different skin tone and body location. This is not validated. The synthetic-only accuracy for 1–2 sample diseases (83.3%, Table 3) is based on only 6 test cases and could reflect label noise from failed transplantations. Please provide a human-expert or at least a per-disease, per-mapping-parameter evaluation of label preservation, and report per-disease synthetic-only accuracies with intervals.","section":"Sec. 3.3"},{"comment":"There is an internal inconsistency about the number of diseases used for parametric generation. Sec. 3.4 says 'For diseases with ≥10 samples' but then defines D = {d_j}_{40}, which equals 13 diseases with >10 samples plus 27 diseases with 2–10 samples (Sec. 3.1). Since the total of 185,400 semantic synthetics uses D=40, diseases with as few as 2 samples were in fact used. This contradicts the abstract's 'as few as 10 training samples' phrasing and the later claim that ~10 samples are sufficient. Please clarify the threshold and, if 2–10 sample diseases were included, adjust the claims and report their generation quality separately.","section":"Sec. 3.4 / Eq. (1)"}],"minor_comments":[{"comment":"The formatting of Table 4 is hard to read: values are not aligned, no ±std are given, and several DPM/EOM entries are exactly 0.500, which should be explained (ties or degenerate predictions?).","section":"Table 4"},{"comment":"The generative quality metrics lack a real-data baseline or comparison; FID values around 88–108 are high in absolute terms. Reporting only max/min ratios across skin tones does not establish 'fairness' of generation quality.","section":"Sec. 4.5 / Table 6"},{"comment":"The relationship between the 65 consolidated disease labels, the 25 single-observation diseases, and the 40 diseases in Eq. (1) should be made explicit in one place; currently the reader must infer it.","section":"Sec. 3.1 / Sec. 3.4"},{"comment":"The phrase 'excluding training synthetics conditioned on downstream test images' should define 'conditioned on' precisely: does it exclude healthy canvases only, or also lesion donors and semantic prompts originating from test images?","section":"Sec. 4.2"}],"recommendation":"major_revision","confidential_remarks":"The paper is a good fit for the venue and the open release is a substantial strength. The main risk is leakage through the healthy-canvas generation; the authors must provide per-fold exclusion details or re-run the protocol. I would also ask for basic confidence intervals before accepting the SOTA claim. The internal inconsistency about the 40-disease set should be resolved in revision."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Tim — my read: the framework and the dataset are the story, not the exact accuracy numbers. What is actually new is the combination of healthy-canvas inpainting, non-parametric lesion mapping for single-sample diseases, and prior-preservation loss anchored on healthy synthetics. That combination is new for dermatology, and releasing 266k+ images, code, and models is a serious, reusable contribution. The authors also do the right thing by benchmarking against PatchAlign on the same folds and seeds, reporting fairness metrics, and including an ablation that separates the contribution of each generation method. Lesion mapping is simple and likely useful for rare diseases, even if the headline SOTA claim needs more support. The biggest problem is leakage. Sec. 4.2 says leakage prevention in one parenthetical — “excluding training synthetics conditioned on downstream test images” — but the generation pipeline is described globally, not per fold. The 309 healthy synthetics come from 334 DDI inputs, and those healthy canvases are then used for lesion-mapped and semantic synthetics. If any healthy canvas is derived from a test-set image, every descendant synthetic inherits background cues like ruler, skin texture, and framing. A ViT can exploit those cues. The paper does not say whether generation was repeated per fold, how many synthetics were excluded, or whether exclusion cascaded to descendants. This is the load-bearing soft spot. It does not have to be a real leak, but the text as written does not rule it out, and it directly affects the 86.4/90.9 numbers. Other soft spots are smaller but worth naming. DDI has 131 test images per fold and F17k has 55, so the headline deltas correspond to a handful of images, and no confidence intervals or significance tests are reported. The DPM fairness metric actually moves against the “leading fairness metrics” claim: 68.8 for Exp. 2 versus 74.9 for PatchAlign. EOM is the real win. The FID values are high in absolute terms, though the authors only claim tone-consistency, not absolute realism. Label preservation for transplanted lesions is another premise that is not verified, but it is secondary to the leakage question. Who is this for: people working on fairness in medical imaging who want augmentation resources and a concrete method to try. Read it for the dataset and the framework; treat the benchmark numbers as provisional until the authors clarify leakage prevention and add uncertainty quantification. I would send it to peer review — the artifact and the framework deserve referee time. But the revision needs per-fold generation details, exclusion counts, and a direct check that synthetic descendants of test images do not appear in training. That is not a cosmetic request; it is the difference between a benchmark result and a plausible one.","headline":"The framework and the open 266k-image release are real contributions, but the headline accuracy numbers rest on a leakage-prevention sentence that is too thin to trust, and the test sets are too small for the claimed precision.","tokens_in":774,"tokens_out":951,"would_cite":true,"duration_ms":37603,"reading_group":"maybe","serious_thinker":"yes","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":[],"model":"deepseek-v4-flash","headline":"A three-stage synthetic-image pipeline trains a skin-cancer classifier to 90.9% accuracy on real clinical images, beating prior state-of-the-art while narrowing skin-tone fairness gaps. Starting from only 656 real biopsy-confirmed images, t","keywords":["dermatology","fairness","synthetic data","diffusion models","lesion mapping","textual inversion","malignancy classification","skin-tone diversity"],"falsifier":"Take a balanced sample of lesion-mapped synthetic images for each disease and skin tone, have board-certified dermatologists classify them, and measure agreement with the donor's original label; if agreement drops materially for cross-tone or rare-disease transplants, the label-preservation premise fails. A simpler quantitative check: train a classifier on synthetics where lesion labels are randomly permuted among skin tones and see if accuracy drops; if it does not, the classifier is using background or tone cues rather than lesion identity.","tokens_in":8409,"feed_emoji":"🩺","tokens_out":4966,"duration_ms":46541,"temperature":0.7,"pith_summary":"The paper claims that a hybrid generative pipeline can largely replace real annotated dermatology data. From 656 real images, it produces 266k+ synthetic images across three complementary routes: healthy-skin inpainting, non-parametric lesion transplant, and parametric diffusion generation. Training a classifier on synthetics alone reaches 86.4% accuracy on the DDI benchmark; adding a real-data fine-tuning pass raises accuracy to 90.9%, above the previous best, while improving Equality of Opportunity from 69.6 to 86.6. The result matters because dark skin tones and rare diseases are exactly where annotated data is scarcest, and the method is designed to generate those cases.","feed_headline":"90.9% accuracy from skin images grown 400x synthetically","feed_subtitle":"Synthetic-only training hits 86.4% and improves skin-tone fairness, even for one-sample diseases.","key_machinery":"The central mechanism is the three-stage cgDDI generator: a latent-diffusion inpainting step that removes lesions to produce healthy skin canvases; a non-parametric lesion-mapping algorithm that pastes a real donor lesion onto a healthy canvas at a controlled location and skin tone; and a parametric semantic generator that fine-tunes a latent diffusion model per disease using textual inversion and low-rank adaptation, anchored by a prior-preservation loss on the healthy synthetics to prevent semantic drift. The non-parametric route is what makes single-sample diseases augmentable, while the parametric route scales diversity for diseases with roughly ten or more samples.","core_discovery":"On the biopsy-confirmed DDI benchmark, synthetic-only training reaches 86.4% accuracy with substantially higher fairness metrics than prior methods; adding a fine-tuning pass on real images lifts accuracy to 90.9%, above the previous best, and raises Equality of Opportunity from 69.6 to 86.6. Accuracy holds even for diseases with only one or two real samples (83.3% from synthetic data alone), demonstrating that single-sample lesions can be turned into trainable data via non-parametric lesion mapping. Cross-dataset experiments show a +13.9 percentage-point accuracy improvement on unseen expert-verified data despite minimal disease overlap.","pith_inferences":["The key untested assumption is that a lesion transplanted onto a healthy canvas of a different skin tone and body site preserves its disease identity; a dermatologist labeling study on lesion-mapped samples would directly test this and could reveal hidden label noise.","The +13.9% cross-dataset gain hints that synthetic data may act as a domain-adaptation mechanism, but the paper does not isolate whether the improvement comes from lesion morphology or from simple skin-tone rebalancing.","The 'about 10 samples' requirement for parametric generation is a soft bound; a systematic sample-size sweep with stronger regularization could reveal whether 3–5 samples suffice, further lowering data needs.","Fairness gains in discriminative classifiers may transfer to other medical imaging domains with similar scarcity imbalances, but that transfer is not demonstrated here and would need its own validation."],"forward_implications":["If the label-preservation assumption holds, synthetic-only training can match or beat real-data baselines, relaxing the need for large expert-annotated datasets.","Single-sample rare diseases become trainable: the 1–2 sample disease class reaches 83.3% accuracy from synthetic data alone.","Fairness improves alongside accuracy: Equality of Opportunity rises from 69.6 to 86.6, indicating more consistent true-positive rates across skin tones.","Cross-dataset transfer improves accuracy by 13.9 percentage points on unseen data with minimal disease overlap, suggesting the synthetic images carry generalizable lesion features.","The released 266k+ synthetic images, code, and generative models let others reproduce or extend the training data without sharing patient images."],"fun_headline_variants":["Fair skin cancer AI trained on synthetic images boosts accuracy","Synthetic skin images lift malignancy detection to 90.9% accuracy","Growing skin dataset 400x with synthetic images improves fairness","Single-sample skin lesions become trainable via synthetic generation","Synthetic-only training hits 86.4% accuracy and fairer outcomes"],"cache_read_input_tokens":2304,"weakest_assumption_plain":"The load-bearing premise is that a synthetic image built from a donor lesion pasted on another patient's healthy skin retains the donor lesion's disease identity and malignancy label; if label preservation fails, especially for rare diseases or cross-skin-tone transplants, the synthetic training set contains label noise that could explain the reported accuracy and fairness gains.","fun_headline_variants_meta":{"raw":{"variants":["Fair skin cancer AI trained on synthetic images boosts accuracy","Synthetic skin images lift malignancy detection to 90.9% accuracy","Growing skin dataset 400x with synthetic images improves fairness","Single-sample skin lesions become trainable via synthetic generation","Synthetic-only training hits 86.4% accuracy and fairer outcomes"]},"model":"deepseek-v4-flash","effort":"low","cost_usd":0.000593,"raw_usage":{"total_tokens":2633,"prompt_tokens":780,"completion_tokens":1853,"prompt_tokens_details":{"cached_tokens":256},"prompt_cache_hit_tokens":256,"prompt_cache_miss_tokens":524,"completion_tokens_details":{"reasoning_tokens":1767}},"tokens_in":524,"tokens_out":1853,"duration_ms":11513,"temperature":1.0,"reasoning_tokens":1767,"cache_read_input_tokens":256,"cache_creation_input_tokens":0},"cache_creation_input_tokens":0},"created_at":"2026-08-02T06:08:14.101572+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Take a balanced sample of lesion-mapped synthetic images for each disease and skin tone, have board-certified dermatologists classify them, and measure agreement with the donor's original label; if agreement drops materially for cross-tone or rare-disease transplants, the label-preservation premise fails. A simpler quantitative check: train a classifier on synthetics where lesion labels are randomly permuted among skin tones and see if accuracy drops; if it does not, the classifier is using background or tone cues rather than lesion identity.","supporting_citations":[],"review_version":2}